⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CUE News
Cue Biopharma, Inc.
Form 8-K
sec.gov
CUE
Cue Biopharma Announces 1-for-30 Reverse Stock Split
globenewswire.com
CUE
Cue Biopharma to Present New Preclinical Data on Lead Autoimmune and Inflammatory Disease Candidate CUE-401 at IMMUNOLOGY2026
globenewswire.com
CUE
Form 8-K
sec.gov
CUE
Cue Biopharma to Receive $7.5 Million Preclinical Milestone Payment from Boehringer Ingelheim Collaboration and License Agreement
globenewswire.com
CUE
Form 8-K
sec.gov
CUE
Form 8-K
sec.gov
CUE
Cue Biopharma Announces CEO Transition
globenewswire.com
CUE
Cue Biopharma to Host Virtual R&D Day Event on April 7, 2026
globenewswire.com
CUE
Cue Biopharma Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
globenewswire.com
CUE